✦ LIBER ✦
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
✍ Scribed by Kohan, Donald E; Fioretto, Paola; Tang, Weihua; List, James F
- Book ID
- 121388168
- Publisher
- Nature Publishing Group
- Year
- 2014
- Tongue
- English
- Weight
- 743 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.